Roche will present the new data at next week's ASCO congress showing that its bispecific antibody glofitamab can achieve high and durable responses in patients with aggressive lymphoma.

The results of the trial will be presented at the ASCO cancer congress tomorrow, and simultaneously published in The Lancet Oncology journal. The SYMPLIFY trial is one of two large-scale community ...

The 2025 ASCO Annual Meeting will be in-person and online, May 30 - June 3, 2025. Become an exhibitor and reach more than 36,400 health care professionals from around the world. Over 400 organizations ...

Abstracts of superior quality have been selected by the ASCO Scientific Program Committee for presentation at the 2025 ASCO Annual Meeting and for publication in the 2025 ASCO Annual Meeting ...

Located within walking distance of historic Old Town Alexandria, the ASCO Conference Center is close to two Metro stations and many of the area’s restaurants and hotels. With five rooms to choose from ...